Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00767026 · ClinicalTrials.gov registry record · Phase 1
COPE Intervention for Parents of Children With Epilepsy
A Phase 1 study of Epilepsy, sponsored by Boston Children's Hospital.
- Completed
- Registry status
- Phase 1
- Development phase
- 88
- Enrollment target
- 1
- Study location
NCT00767026 is a Phase 1 study of Epilepsy that has completed, run by Boston Children's Hospital. The registered enrollment target is 88 participants, below the 952-participant average among 160 other Epilepsy trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00767026, a Phase 1 study of Epilepsy, has completed, sponsored by Boston Children's Hospital.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 88 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine if the program Creating Opportunities for Parent Empowerment (COPE) is feasible to administer to parents of children with neurological conditions. The goal of the study is to empower parents by providing them with educational materials designed to teach them how to foster healthy coping skills in their child.
Conditions Studied
Interventions
- BEHAVIORAL Standard education
- BEHAVIORAL COPE (Creating Opportunities for Parent Empowerment)
Study Locations (1)
Massachusetts
- Children's Hospital Boston - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2008-01 |
| Est. Completion | 2010-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00767026
The ClinicalTrials.gov registry entry for NCT00767026 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 88 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 952-participant average among 160 other Epilepsy trials with a reported enrollment target (91% lower). The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Epilepsy appearing as the primary indexed condition, and to 2 interventions - of which Standard education is the first listed.
NCT00767026 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00767026 about?
NCT00767026 is a clinical study titled "COPE Intervention for Parents of Children With Epilepsy". The purpose of this study is to determine if the program Creating Opportunities for Parent Empowerment (COPE) is feasible to administer to parents of children with neurological conditions. The goal of the study is to empower parents by providing them with educational materials designed to teach them...
What is the current status of trial NCT00767026?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 88 participants. The study started on 2008-01. Estimated completion is 2010-12.
What conditions does trial NCT00767026 study?
This clinical trial studies the following conditions: Epilepsy.
What interventions are being tested in trial NCT00767026?
The interventions under investigation include: Standard education (BEHAVIORAL), COPE (Creating Opportunities for Parent Empowerment) (BEHAVIORAL).
Who is sponsoring clinical trial NCT00767026?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00767026 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Epilepsy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Study to Evaluate the Relative Bioavailability of a New Formulation of NPT 2042 Soft-Gelatin Capsules Compared to the Original Formulation of NPT 2042
RECRUITING · Phase 1
-
Understanding Ketamine's Dissociative Effects (KD Study)
RECRUITING · Phase 1
-
A Clinical Trial of PRAX-222 in Pediatric Participants With Early Onset SCN2A Developmental and Epileptic Encephalopathy
RECRUITING · Phase 1
-
A Safety, Tolerability, and Preliminary Efficacy of Low-intensity Focused Ultrasound Neuromodulation in Patients With Drug-resistant Epilepsy
RECRUITING · Phase 1
-
Microelectrode Recordings From the Vagus Nerve in Awake Humans
RECRUITING · Phase 1
-
Investigation of Blood-Brain-Barrier Breakdown Using Manganese Magnetic Resonance Imaging in Drug-Resistant Epilepsy
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.